Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate Dose-Ranging Study in Axillary Hyperhidrosis
NCT02016885Phase 2Completed
- Sponsor
- Journey Medical Corporation
- Start
- Nov 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycopyrronium in axillary hyperhidrosis, sponsored by Journey Medical Corporation. Started Nov 2013; status: completed.
02
Drugs
glycopyrronium
03
Conditions
axillary hyperhidrosis
Beyond the preview
Go deeper on NCT02016885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016885.